Your browser doesn't support javascript.
loading
Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition.
Cervenka, Iris; Al Rahmoun, Marie; Mahamat-Saleh, Yahya; Fournier, Agnès; Boutron-Ruault, Marie-Christine; Severi, Gianluca; Caini, Saverio; Palli, Domenico; Ghiasvand, Reza; Veierod, Marit B; Botteri, Edoardo; Tjønneland, Anne; Olsen, Anja; Fortner, Renée T; Kaaks, Rudolf; Schulze, Matthias B; Panico, Salvatore; Trichopoulou, Antonia; Dessinioti, Clio; Niforou, Katerina; Sieri, Sabina; Tumino, Rosario; Sacerdote, Carlotta; Bueno-de-Mesquita, Bas; Sandanger, Torkjel M; Colorado-Yohar, Sandra; Sánchez, Maria J; Gil Majuelo, Leire; Lujan-Barroso, Leila; Ardanaz, Eva; Merino, Susana; Isaksson, Karolin; Butt, Salma; Ljuslinder, Ingrid; Jansson, Malin; Travis, Ruth C; Khaw, Kay-Tee; Weiderpass, Elisabete; Dossus, Laure; Rinaldi, Sabina; Kvaskoff, Marina.
Affiliation
  • Cervenka I; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Al Rahmoun M; Gustave Roussy, Villejuif, France.
  • Mahamat-Saleh Y; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Fournier A; Gustave Roussy, Villejuif, France.
  • Boutron-Ruault MC; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Severi G; Gustave Roussy, Villejuif, France.
  • Caini S; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Palli D; Gustave Roussy, Villejuif, France.
  • Ghiasvand R; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Veierod MB; Gustave Roussy, Villejuif, France.
  • Botteri E; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Tjønneland A; Gustave Roussy, Villejuif, France.
  • Olsen A; Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research, Prevention and Oncology Network Institute (ISPRO), Florence, Italy.
  • Fortner RT; Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research, Prevention and Oncology Network Institute (ISPRO), Florence, Italy.
  • Kaaks R; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Schulze MB; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Panico S; Department of Bowel Cancer Screening, Cancer Registry of Norway, Oslo University Hospital, Oslo, Norway.
  • Trichopoulou A; Norwegian National Advisory Unit for Women's Health, Women's Clinic, Oslo University Hospital, Oslo, Norway.
  • Dessinioti C; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Niforou K; University of Copenhagen, Copenhagen, Denmark.
  • Sieri S; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Tumino R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sacerdote C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bueno-de-Mesquita B; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Sandanger TM; Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany.
  • Colorado-Yohar S; Dipartimento di medicina clinica e chirurgia, Federico II University, Naples, Italy.
  • Sánchez MJ; Hellenic Health Foundation, Athens, Greece.
  • Gil Majuelo L; Hellenic Health Foundation, Athens, Greece.
  • Lujan-Barroso L; 1st Department of Dermatology Andreas Syggros Hospital University of Athens, Athens, Greece.
  • Ardanaz E; Hellenic Health Foundation, Athens, Greece.
  • Merino S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Via Venezian, Milan, Italy.
  • Isaksson K; Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale (ASP), Ragusa, Italy.
  • Butt S; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Ljuslinder I; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Jansson M; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Travis RC; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, London, United Kingdom.
  • Khaw KT; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Weiderpass E; Department of Community Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
  • Dossus L; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Rinaldi S; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Kvaskoff M; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellin, Colombia.
Int J Cancer ; 146(12): 3267-3280, 2020 06 15.
Article in En | MEDLINE | ID: mdl-31506954
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Estrogen Replacement Therapy / Contraceptives, Oral, Hormonal / Melanoma Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2020 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Estrogen Replacement Therapy / Contraceptives, Oral, Hormonal / Melanoma Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2020 Type: Article Affiliation country: France